Photodynamic Therapy for latrogenic CNV Due to Laser Photocoagulation in Central Serous Chorioretinopathy

The authors report the result of photodynamic therapy for latrogenic choroldal neovascularization from focal argon laser photocoagulation In a case with central Serous chorioretinopathy. A 45-year-old woman who developed choroldal neovascularization after focal argon laser photocoagulation for chronic central Serous chorioretinopathy was treated with Ocular phorodynamic therapy with verteporfin. Choroidal neovascularization became inactive clinically a month after photodynamic therapy. Fluorescein angiography and optical coherence tomography demonstrated the resolved choroidal neovascularization. Baseline visual acuity improved from 20/40 to 20/20 after photodynamic therapy,. The patients condition remained stable 2 years postoperatively. Photodynamic therapy was beneficial for the outcome of iatrogenic choroldal neovascularization that developed after laser treatment for longstanding central Serous chorioretinopathy [Ophthalmic Surg Lasers Imaging 2009;40:405-408.]